OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Recommended Conferences for Diabetic retinopathy

Diabetic retinopathy


As per available reports 2 National Symposium, 49 Open Access Articles, 68 Conference Proceedings , is presently dedicated  exclusively to Diabetic retinopathy.

Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. Each year in the United States, diabetic retinopathy accounts for 12% of all new cases of blindness. It is caused by changes in the blood vessels of the retina. In some people with diabetic retinopathy, blood vessels may swell and leak fluid.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance:

In other people, abnormal new blood vessels grow on the surface of the retina. The retina is the light-sensitive tissue at the back of the eye. A healthy retina is necessary for good vision. Diabetic retinopathy usually affects both eyes. People who have diabetic retinopathy often don't notice changes in their vision in the disease's early stages. But as it progresses, diabetic retinopathy usually causes vision loss that in many cases cannot be reversed. It is an ocular manifestation of diabetes, a systemic disease, which affects up to 80 percent of all patients who have had diabetes for 10 years or more. Despite these intimidating statistics, research indicates that at least 90% of these new cases could be reduced if there was proper and vigilant treatment and monitoring of the eyes. The longer a person has diabetes, the higher his or her chances of developing diabetic retinopathy.

Market Analysis:

Global Diabetic Retinopathy Market is expected to reach USD 10.11 billion by 2022, according to a new study by Grand View Research Inc. Diabetic retinopathy is considered as a serious sight threatening complication that results due to long term diabetes. The treatment line selection for diabetic retinopathy depends on the severity of the condition and may require intraocular injections, anti VEGF drugs, laser surgery or vitrectomy. Increasing incidences of diabetes, rising geriatric population base and the growing demand for early detection are some high impact rendering drivers of the diabetic retinopathy market.

International symposium and workshops

  • Advanced Technologies & Treatments for Diabetes, 3–6 February 2016, Italy
  • World Congress on Interventional Therapies for Type 2 Diabetes & DSS II, 28–30 September 2015, United Kingdom
  • Diabetes: An Overview, 8 October 2015, London

List of Best International Conferences:

Aug 22-24, 2016, Sao Paulo, Brazil

November 02-04, 2015 Atlanta, Georgia, USA

February 29-March 02, 2016 Philadelphia, USA

June 06-08, 2016 Dallas, USA

Dec 5-7, 2016, Baltimore, USA

Nov 14-16, 2016, Dubai, UAE

Oct 20-22, 2016, Dubai, UAE

September 29-October 1, 2016, Toronto, Canada

Oct 17-19, 2016, Kuala Lumpur, Malaysia

Aug 22-24, 2016, Kuala Lumpur, Malaysia

Aug 8-10, 2016, Birmingham, UK

July 14-16, 2016, Cologne, Germany

July 11-13, 2016, Brisbane, Australia

Feb 29-Mar 2, 2016, Philadelphia, USA

Relevant Society and Associations

  • Diabetes Indian Association
  • Canadian Diabetes Association
  • International Diabetes Federation
  • Diabetes Australia
  • Austrian Diabetes Association.
  • Diabetes UK
  • Diabetes South Africa.
  • Spanish Diabetes Society (Spain).
  • Swedish Diabetes Association.
  • Korean Diabetes Association

Companies

  • Lantus
  • Januvia
  • NovoLog/NovoRapid
  • Humalog
  • Victoza
  • Levemir
  • Human insulin and devices
  • Janumet
  • NovoMix 30
  • Humulin R

This page will be updated regularly.

This page was last updated on 12th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising